Chalice Brands (CHALF) Stock Price, News & Analysis
Company Description
Chalice Brands (OTC Link: CHALF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $11.6M.
This page collects what Stock Titan holds for CHALF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chalice Brands (CHALF) stock last closed at $0.0000. At a market capitalization of $11.6M, CHALF is classified as a micro-cap stock.
Latest News
Chalice Brands has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include management, acquisition. View all CHALF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Chalice Brands (CHALF) currently stands at 55 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Chalice Brands (CHALF) currently stands at 1.4 days, up 38% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 38% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CHALF Company Profile & Sector Positioning
Chalice Brands (CHALF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CHALF often look at related companies in the same sector, including Red Light Hollan (TRUFF), Argent BioPharma (RGTLF), Ayr Wellness Inc. (AYRWF), Elixxer (ELIXF), and Redwood Scientif (RSCI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CHALF's relative position within its industry.